{"id":"NCT01356498","sponsor":"Savient Pharmaceuticals","briefTitle":"Open-Label Extension Study for Patients Who Completed a Phase 3 Double-blind Study of PEG-uricase for Symptomatic Gout","officialTitle":"Multicenter, Open Label Extension Study of 8 mg PEG-uricase in Subjects Who Completed Protocols C0405 or C0406 for Symptomatic Gout","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-12","primaryCompletion":"2010-01","completion":"2010-01","firstPosted":"2011-05-19","resultsPosted":"2011-12-02","lastUpdate":"2011-12-02"},"enrollment":151,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Gout"],"interventions":[{"type":"BIOLOGICAL","name":"pegloticase","otherNames":[]}],"arms":[{"label":"q2 RCT","type":"EXPERIMENTAL"},{"label":"q4 RCT","type":"EXPERIMENTAL"},{"label":"Placebo in RCT","type":"EXPERIMENTAL"}],"summary":"This is an open-label extension phase of two double-blind, placebo-controled Phase 3 protocols evaluating PEG-uricase in the treatment of hyperuricemic subjects with symptomatic gout. The purpose of this study is to provide a continuation of treatment to subjects completing the double-blind studies and obtain long-term safety and efficacy data.","primaryOutcome":{"measure":"Uric Acid (mg/dL)","timeFrame":"Week 13, Week 25, Week 53, Week 101","effectByArm":[{"arm":"q2 RCT, Responder","deltaMin":1.33,"sd":3.103},{"arm":"q4 RCT, Responder","deltaMin":1.91,"sd":4.082},{"arm":"Placebo in RCT, q2 in OLE","deltaMin":5.06,"sd":4.538},{"arm":"q2 RCT, Non-responder","deltaMin":9.76,"sd":1.346},{"arm":"q4 RCT Non-responder","deltaMin":9.66,"sd":2.529},{"arm":"Placebo in RCT, q4 in OLE","deltaMin":8.08,"sd":3.561}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":5},"locations":{"siteCount":22,"countries":["United States"]},"refs":{"pmids":["31203212","24588936","24286509"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":35},"commonTop":["Gout","Infusion Related Reaction","Arthralgia","Upper Respiratory Tract Invection","Pain in Extremity"]}}